Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02442739
Recruitment Status : Withdrawn (PI voluntary closure due to low accrual)
First Posted : May 13, 2015
Last Update Posted : November 6, 2018
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Scott A. Irwin, MD, PhD, Cedars-Sinai Medical Center

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : November 3, 2017
Actual Study Completion Date : November 3, 2017